sellModerate cluster of 310b5-1 plan
Xiaodong Wang sold $7.8M of ONC
director, other at BeiGene, Ltd.. 41,760 shares at an average of $186.90, traded Dec 10, 2024, filed Dec 12, 2024.
Warning score
40Value
$7.8M
41,760 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +25Trade size$7.8M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001651308-24-000166, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 10, 2024 | MOption exercise American Depositary Shares10b5-1 | +41,760 | $6.50 | $271k | 41,760 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -2,600 | $183.60 | $477k | 39,160 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -7,063 | $184.83 | $1.3M | 32,097 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -9,956 | $185.73 | $1.8M | 22,141 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -9,266 | $186.99 | $1.7M | 12,875 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -6,350 | $187.60 | $1.2M | 6,525 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -1,300 | $188.79 | $245k | 5,225 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -1,833 | $190.57 | $349k | 3,392 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -993 | $191.78 | $190k | 2,399 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -1,374 | $192.61 | $265k | 1,025 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -725 | $194.01 | $141k | 300 | Dec 12, 2024 |
| Dec 10, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -300 | $195.67 | $59k | 0 | Dec 12, 2024 |
| Dec 10, 2024 | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -542,880 | $0.00 | $0 | 3,257,287 | Dec 12, 2024 |
Related signals
Other insiders at BeiGene, Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 49Moderate | BeiGene, Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 83Strong | BeiGene, Ltd. | John Oyler Chief Executive Officer | $830k 3,174 shares | -100% | |
| 48Moderate | BeiGene, Ltd. | Xiaodong Wang director, other | $533k 2,007 shares | -100% | |
| 70Notable | BeiGene, Ltd. | Xiaobin Wu President and COO | $354k 1,363 shares | -100% | |
| 63Notable | BeiGene, Ltd. | Lai Wang Global Head of R&D | $267k 1,028 shares | -100% | |
| 85Strong | BeiGene, Ltd. | John Oyler Chief Executive Officer | $1.4M 5,140 shares | -100% | |
| 74Notable | BeiGene, Ltd. | Xiaobin Wu President and COO | $568k 2,173 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.